Buying an existing medical spa is financed primarily via SBA 7(a) — the only standard loan program that finances goodwill (patient base + device fleet + brand) alongside tangible assets at 10–15% down; conventional acquisition loans are available for asset-heavy practices where equipment and leasehold dominate; both require documented medical director continuity and CPOM-compliant entity structure.
Buying an existing medical spa involves financing three overlapping asset classes simultaneously: (1) tangible equipment (laser and body-contouring devices, treatment furniture, skincare inventory), (2) leasehold improvements (built-out treatment rooms, plumbing, electrical), and (3) goodwill — the patient base, membership list, brand reputation, medical director relationships, and trained staff that make the practice revenue-generative from day one. Conventional lenders are comfortable with the first two categories; most will not finance goodwill. SBA 7(a) is the acquisition vehicle that solves the goodwill gap: it finances intangibles up to 70–90% of appraised value as part of a total acquisition loan. For a med spa selling for $500,000–$1.5M — a typical range for an established single-location practice — SBA 7(a) gets the deal done at 10–15% buyer equity injection versus 25–40% for conventional acquisition financing.
Med spa acquisition underwriters evaluate the target practice on five dimensions: (1) Revenue durability — trailing 12-month revenue normalized for any anomalous periods; membership ARR weighted more heavily than transactional service revenue because it is more predictable. (2) Device fleet condition and age — a practice with $400,000 in 2-year-old FDA-cleared devices is a materially different acquisition than one with $400,000 in 6-year-old platforms nearing obsolescence; buyers should request device serial numbers and 510(k) status and factor replacement costs into the purchase price and financing request. (3) Medical director continuity — if the seller is the medical director, the buyer must secure a new or transitioning medical director before close or within a documented transition window; lenders require a written transition plan or executed replacement agreement. (4) CPOM-compliant buyer entity — the purchasing entity must be organized in compliance with state CPOM law before SBA eligibility determination; organizing a PC or PLLC post-LOI with a physician co-owner is a common path for non-physician buyers. (5) Goodwill valuation — the SBA requires an independent business valuation for acquisition loans over $250,000 where goodwill exceeds 25% of total purchase price; the appraiser values the patient base, memberships, brand, and non-compete agreements.
The SBA 7(a) program is the dominant financing vehicle for med spa acquisitions because it finances goodwill — the single largest value component in most established practices. Under 13 CFR Part 121, NAICS 812199 entities qualify at average annual receipts under $8M. SBA requires an independent business valuation when goodwill exceeds 25% of total transaction value and the loan amount exceeds $250,000. The SBA's goodwill-inclusion policy means that a $1M acquisition with $600,000 in goodwill can close at $100,000–$150,000 buyer equity — versus $250,000–$400,000 for a conventional lender or a bank that refuses to finance intangibles.
Med spa acquisition underwriting involves several factors beyond standard business acquisition: (1) Medical director transition risk — the most common deal-killer in med spa acquisitions; if the seller's medical director will not stay through a transition period, the buyer must identify and contract with a replacement MD/NP/PA before lenders will fund; a gap in medical direction makes the practice temporarily non-operational under most state regulations. (2) Device age and obsolescence — a laser device with 5+ years of use and no manufacturer service agreement may have near-zero residual collateral value; buyers should negotiate price reductions for aging devices and factor in the cost of replacement into the total financing request. (3) State CPOM buyer-entity requirements — some states require a physician to hold at least 51% ownership for CPOM compliance; other states permit any licensed healthcare provider to own 100%; buyers must organize the acquisition entity under the applicable state framework before SBA eligibility review. (4) Non-compete covenants — the seller's non-compete agreement (typically 2–5 years, 10–25 miles) is a significant intangible asset protecting patient base retention; a poorly structured non-compete can result in patient attrition post-close that destroys the DSCR model. (5) DEA registration continuity — if the practice dispenses regulated substances, the buyer must obtain their own DEA registration before post-close operations; DEA registration transfer is not standard and takes 3–6 months to secure.